rethinkPeptides Search
Menu
Study breakdown

Immune Cells Release Opioid Peptides at Injury Sites to Produce Local Pain Relief

Animal StudyModerate evidence
The takeaway

Immune cells at inflammation sites release opioid peptides that activate pain nerve receptors locally, producing targeted pain relief without involving the brain — a natural neuroimmune painkilling mechanism.

Immune cells as local painkillers

Opioid peptides released from immune cells at inflammation sites activate peripheral nerve receptors to block pain signals

What the researchers found

Immune cells in inflamed tissue release opioid peptides that activate receptors on sensory nerve terminals, producing local pain relief. This represents a newly discovered neuroimmune analgesic pathway.

Why it matters

This revealed that the immune system can directly reduce pain at inflammation sites. It is a natural local painkilling mechanism that does not involve the brain.

How the study worked

Rats with hind paw inflammation were subjected to cold water swim stress. Local opioid content in immune cells, opioid receptors on nerves, and effects of local antibody injections and cyclosporine were tested.

What this study cannot tell us

Animal study using an acute inflammation model. The specific immune cell types and opioid peptides involved were not fully characterized. Translation to chronic pain conditions is uncertain.

How to read the evidence

Moderate animal study demonstrating a novel neuroimmune mechanism. The local versus systemic naloxone experiments provide compelling evidence for a peripheral mechanism.

When this study was published

Published in 1990. This peripheral immune opioid mechanism has been extensively confirmed and is now a foundation of peripheral opioid analgesic research.

The bigger picture

This discovery showed the immune system has a built-in pain management function. When immune cells arrive at an injury, they release natural painkillers alongside their inflammation-fighting chemicals. This concept has inspired development of peripherally-acting opioid drugs that target pain at its source without brain-based side effects.

Questions still open

  • Can this immune opioid mechanism be therapeutically enhanced?
  • Is this local opioid release impaired in chronic inflammatory conditions?

Common questions

How do immune cells produce pain relief?
When immune cells (like lymphocytes and macrophages) migrate to injured tissue, they carry and release opioid peptides. These natural painkillers bind to opioid receptors on nearby pain-sensing nerves, reducing pain signals right at the injury site.
Could this lead to better pain medications?
Yes. By understanding this peripheral opioid mechanism, researchers are developing pain drugs that work only at the site of injury without entering the brain — potentially providing relief without addiction, sedation, or respiratory depression.

Read the original research

Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation.

Proceedings of the National Academy of Sciences of the United States of America, 87(15), 5935-9

Citation

Stein, C; Hassan, A H; Przewłocki, R; Gramsch, C; Peter, K; Herz, A. (1990). Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation.. Proceedings of the National Academy of Sciences of the United States of America, 87(15), 5935-9.